<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02650284</url>
  </required_header>
  <id_info>
    <org_study_id>MAKORCT-15</org_study_id>
    <nct_id>NCT02650284</nct_id>
  </id_info>
  <brief_title>A Trial Evaluating TKR Compared to BKR Performed Using Stryker's Mako Robot</brief_title>
  <official_title>A Prospective, Randomised Controlled Trial Evaluating Total Knee Replacement With the Stryker Triathlon Primary Total Knee System Performed Using Stryker's Robotic-arm Assisted Surgery System, Mako, Compared to Bicompartmental Knee Replacement With Restoris MCK Multicompartmental Knee System Performed Using Stryker's Robotic-arm Assisted Surgery System, Mako</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stryker South Pacific</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stryker South Pacific</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective, randomised controlled trial evaluating Total Knee Replacement with the Stryker&#xD;
      Triathlon Primary Total Knee System, compared to Bicompartmental Knee Replacement with&#xD;
      Restoris MCK Multicompartmental Knee System performed using Stryker's Robotic-arm assisted&#xD;
      surgery system, Mako.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a prospective, randomised clinical study comparing clinical outcomes of Knee&#xD;
      Replacement using the Oxford Knee Score (OKS), in patients receiving either Bicompartmental&#xD;
      Knee Replacement performed using Stryker's robotic-arm assisted surgery system Mako, to Total&#xD;
      Knee Replacement using the Triathlon Total Knee System performed with either conventional&#xD;
      instrumentation or navigation. Functional and radiographic outcomes will be additionally&#xD;
      collected as part of this study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Participant recruitment difficulties. Ruling to terminate study made Oct 2019&#xD;
  </why_stopped>
  <start_date type="Actual">August 12, 2015</start_date>
  <completion_date type="Actual">March 6, 2019</completion_date>
  <primary_completion_date type="Actual">March 6, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oxford Knee Score</measure>
    <time_frame>24 months/ 2 years</time_frame>
    <description>Comparing clinical outcomes using the Oxford Knee Score. The OKS is a participant completed 12 question form on activities of daily living that assess function and pain. Scores can range from 0 to 48 with lower scores indicating a poor outcome and higher scores indicating a more satisfactory joint outcome.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Health Related Quality of Life EQ-5D</measure>
    <time_frame>24 months/ 2years</time_frame>
    <description>Comparing functional and clinical outcomes using the EQ-5D. The EQ-5D-3L descriptive system comprises the following 5 dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 3 levels: no problems, some problems, extreme problems. The participant is asked to indicate his/her health state by indicating the most appropriate level for each of the 5 dimensions. Responses may be converted into a single summary index by applying a formula that essentially attaches values (also called weights) to each of the levels in each dimension. The index can be calculated by deducting the appropriate weights from 1= the value for full health. The EQ VAS records the participant's self-rated health on a vertical, visual analogue scale where the endpoints are labelled from 100 ='Best imaginable health state' to 0= 'Worst imaginable health state'.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VAS Pain</measure>
    <time_frame>24 months/ 2years</time_frame>
    <description>Comparing functional and clinical outcomes using the VAS pain. Pain at rest and pain during mobilization are measured using a 10 centimeter Visual Analogue Scale (VAS). Participants are asked to indicate their level of pain with 0 being no pain and 100 being the worst pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>New Knee Society Score (KSS)</measure>
    <time_frame>24 months/ 2years</time_frame>
    <description>Comparing functional and clinical outcomes using the KSS. The Knee Society Clinical Rating System is comprised of two distinct sub-scores: one for pain, range of motion (ROM) and joint stability, and one for functional parameters. Sub-scores range from a minimum score of 0 to a maximum of 100 points. Although the specific scores are not distinguished as &quot;excellent,&quot; &quot;good,&quot; &quot;fair,&quot; or &quot;poor,&quot; a higher value represents a better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Forgotten Joint Score (FJS)</measure>
    <time_frame>24 months/ 2years</time_frame>
    <description>Comparing functional and clinical outcomes using the FJS. The Forgotten Joint Score (FJS) is a 12 question form that asks the patient their level of awareness of their artificial joint in 12 scenarios commonly encountered in daily life. Scores can range from 0 to 100 with a higher score indicating a better outcome (high degree of forgetting the joint in everyday life).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Loosening, Reoperation and Revision</measure>
    <time_frame>6 weeks, 3 months, 12 months, 24 months</time_frame>
    <description>To compare incidence of loosening, reoperation and revision rates. The incidence (ie number of participants who experienced lossening, reoperation or revision) will be counted and presented as a whole number or percentage of the total number of patients, however they will be identified from analysing Xrays and checking Serious Adverse Event/ Adverse Event reports.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Hospital Stay</measure>
    <time_frame>6 weeks</time_frame>
    <description>To compare length of hospital stay between the two arms of the study</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">18</enrollment>
  <condition>Non-inflammatory Degenerative Joint Disease</condition>
  <arm_group>
    <arm_group_label>Bicompartmental Knee Replacement (BKR)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Receiving Restoris MCK Multicompartmental Knee System for Bicompartmental Knee Replacement (BKR). Surgery performed using Stryker's robotic-arm assisted surgery system Mako</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Total Knee Replacement (TKR)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Receiving Stryker Triathlon Primary Total Knee System for Total Knee Replacement. Surgery performed using Stryker's robotic-arm assisted surgery system Mako</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Stryker Triathlon Primary Total Knee System</intervention_name>
    <description>Total Knee Replacement</description>
    <arm_group_label>Total Knee Replacement (TKR)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Restoris MCK Multicompartmental Knee System</intervention_name>
    <description>Bicompartmental Knee Replacement</description>
    <arm_group_label>Bicompartmental Knee Replacement (BKR)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. The patient is a suitable candidate for a Bicompartmental Knee Replacement and has&#xD;
             moderate to severe patellofemoral wear and medial compartment wear (surgeons&#xD;
             discretion)&#xD;
&#xD;
          2. The patient has no fixed flexion greater than 10 degrees.&#xD;
&#xD;
          3. The patient has maximal flexion greater than 100 degrees&#xD;
&#xD;
          4. The patient has a passively correctable varus deformity&#xD;
&#xD;
          5. The patient has a functionally Intact Anterior Cruciate Ligament (ACL.)&#xD;
&#xD;
          6. The patient has no significant patellofemoral malalignment&#xD;
&#xD;
          7. The patient has negligible lateral compartment degeneration with no appreciable loss&#xD;
             of cartilage height (surgeon's discretion).&#xD;
&#xD;
          8. The patient has pain that is not localised to the medial compartment only&#xD;
&#xD;
          9. The patient is a male or non-pregnant female.&#xD;
&#xD;
         10. The patient has signed the study specific, Human Research Ethics Committee (HREC)-&#xD;
             approved Informed Consent document and is willing and able to comply with the&#xD;
             specified pre-operative and post-operative clinical and radiographic evaluations&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. The patient has a clinically deficient ACL and cruciate and collateral ligament&#xD;
             insufficiency on CT arthrogram.&#xD;
&#xD;
          2. The patient is undergoing revision surgery&#xD;
&#xD;
          3. The patient has greater than 10° of hyperextension, greater than 10° of varus or&#xD;
             valgus deformity, greater than 10° Flexion Contracture&#xD;
&#xD;
          4. The patient has active, local infection or previous intra-articular infection&#xD;
&#xD;
          5. The patient has skeletal immaturity&#xD;
&#xD;
          6. The patient is without sufficient bone stock to allow appropriate insertion and&#xD;
             fixation of the prosthesis&#xD;
&#xD;
          7. The patient's weight, age or activity level might cause extreme loads and early&#xD;
             failure of the system (surgeons discretion).&#xD;
&#xD;
          8. The patient has a systemic or local condition that would limit the ability to assess&#xD;
             the performance of the device e.g. neuromuscular or neurosensory deficiency, disorder&#xD;
             leading to progressive bone deterioration (including rheumatoid arthritis and&#xD;
             osteoporosis), or patient is immunologically suppressed.&#xD;
&#xD;
          9. Patient has a cognitive impairment, an intellectual disability or a mental illness&#xD;
             that is considered by the investigator to inhibit the patient's capacity to consent to&#xD;
             research and the ability to participate in it&#xD;
&#xD;
         10. Patients with tricompartmental disease are contraindicated from the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gavin Clark, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Perth Hip and Knee and St John of God Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Perth Hip &amp; Knee</name>
      <address>
        <city>Subiaco</city>
        <state>Western Australia</state>
        <zip>6008</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>January 6, 2016</study_first_submitted>
  <study_first_submitted_qc>January 7, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 8, 2016</study_first_posted>
  <results_first_submitted>December 20, 2020</results_first_submitted>
  <results_first_submitted_qc>May 10, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">June 4, 2021</results_first_posted>
  <last_update_submitted>May 10, 2021</last_update_submitted>
  <last_update_submitted_qc>May 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Joint Diseases</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>February 22, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/84/NCT02650284/Prot_SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form: Patients receiving CT but NO Arthrogram</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>February 22, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/84/NCT02650284/ICF_001.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form: Patients receiving CT WITH Arthrogram</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>February 22, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/84/NCT02650284/ICF_002.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Upon being assessed against the inclusion and exclusion criteria, suitable patients were randomised to one arm of the study.</recruitment_details>
      <pre_assignment_details>In addition to the 8 Bicompartmental and 9 Total Knee replacement patients, 1 patient in the study was not randomised prior to surgery.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Bicompartmental Knee Replacement (BKR)</title>
          <description>Receiving Restoris MCK Multicompartmental Knee System for Bicompartmental Knee Replacement (BKR). Surgery performed using Stryker's robotic-arm assisted surgery system Mako&#xD;
Restoris MCK Multicompartmental Knee System: Bicompartmental Knee Replacement</description>
        </group>
        <group group_id="P2">
          <title>Total Knee Replacement (TKR)</title>
          <description>Receiving Stryker Triathlon Primary Total Knee System for Total Knee Replacement. Surgery performed using Stryker's robotic-arm assisted surgery system Mako&#xD;
Stryker Triathlon Primary Total Knee System: Total Knee Replacement</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Consent incorrectly taken</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>1 patient in the Total Knee study arm was consented incorrectly and their data could not be used in analyses (i.e. reducing the number of participants in this study arm to 8).</population>
      <group_list>
        <group group_id="B1">
          <title>Bicompartmental Knee Replacement (BKR)</title>
          <description>Receiving Restoris MCK Multicompartmental Knee System for Bicompartmental Knee Replacement (BKR). Surgery performed using Stryker's robotic-arm assisted surgery system Mako&#xD;
Restoris MCK Multicompartmental Knee System: Bicompartmental Knee Replacement</description>
        </group>
        <group group_id="B2">
          <title>Total Knee Replacement (TKR)</title>
          <description>Receiving Stryker Triathlon Primary Total Knee System for Total Knee Replacement. Surgery performed using Stryker's robotic-arm assisted surgery system Mako&#xD;
Stryker Triathlon Primary Total Knee System: Total Knee Replacement</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="8"/>
            <count group_id="B2" value="8"/>
            <count group_id="B3" value="16"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="8"/>
                    <count group_id="B2" value="8"/>
                    <count group_id="B3" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65.0" spread="4.56"/>
                    <measurement group_id="B2" value="64.0" spread="4.85"/>
                    <measurement group_id="B3" value="65" spread="4.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="8"/>
                    <count group_id="B2" value="8"/>
                    <count group_id="B3" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Australia</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="8"/>
                    <count group_id="B2" value="8"/>
                    <count group_id="B3" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Oxford Knee Score</title>
        <description>Comparing clinical outcomes using the Oxford Knee Score. The OKS is a participant completed 12 question form on activities of daily living that assess function and pain. Scores can range from 0 to 48 with lower scores indicating a poor outcome and higher scores indicating a more satisfactory joint outcome.</description>
        <time_frame>24 months/ 2 years</time_frame>
        <population>The number of recruited patients did not reach the required sample size. 1 patient in the Total Knee study arm was consented incorrectly and their data could not be used in analyses (i.e. reducing the number of participants in this study arm to 8).</population>
        <group_list>
          <group group_id="O1">
            <title>Bicompartmental Knee Replacement (BKR)</title>
            <description>Receiving Restoris MCK Multicompartmental Knee System for Bicompartmental Knee Replacement (BKR). Surgery performed using Stryker's robotic-arm assisted surgery system Mako&#xD;
Restoris MCK Multicompartmental Knee System: Bicompartmental Knee Replacement</description>
          </group>
          <group group_id="O2">
            <title>Total Knee Replacement (TKR)</title>
            <description>Receiving Stryker Triathlon Primary Total Knee System for Total Knee Replacement. Surgery performed using Stryker's robotic-arm assisted surgery system Mako&#xD;
Stryker Triathlon Primary Total Knee System: Total Knee Replacement</description>
          </group>
        </group_list>
        <measure>
          <title>Oxford Knee Score</title>
          <description>Comparing clinical outcomes using the Oxford Knee Score. The OKS is a participant completed 12 question form on activities of daily living that assess function and pain. Scores can range from 0 to 48 with lower scores indicating a poor outcome and higher scores indicating a more satisfactory joint outcome.</description>
          <population>The number of recruited patients did not reach the required sample size. 1 patient in the Total Knee study arm was consented incorrectly and their data could not be used in analyses (i.e. reducing the number of participants in this study arm to 8).</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Oxford pre-operative</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8"/>
                    <count group_id="O2" value="8"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.63" spread="8.14"/>
                    <measurement group_id="O2" value="26.75" spread="8.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Oxford 6-weeks</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8"/>
                    <count group_id="O2" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.00" spread="6.69"/>
                    <measurement group_id="O2" value="30.14" spread="3.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Oxford 3-months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8"/>
                    <count group_id="O2" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39.00" spread="3.61"/>
                    <measurement group_id="O2" value="33.29" spread="7.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Oxford 12-months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="7"/>
                    <count group_id="O2" value="6"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.43" spread="4.17"/>
                    <measurement group_id="O2" value="40.33" spread="7.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Oxford 24-months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="5"/>
                    <count group_id="O2" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41.20" spread="5.49"/>
                    <measurement group_id="O2" value="43.75" spread="3.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison between groups at pre-operation timepoint.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Equivalence defined as less than or equal to 1 standard deviation between the two means.</non_inferiority_desc>
            <p_value>0.46</p_value>
            <p_value_desc>The number of recruited patients did not reach the required sample size. Power score assessments no longer hold, thus there is low confidence in the findings.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison between groups at 6-week timepoint.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Equivalence defined as less than or equal to 1 standard deviation between the two means.</non_inferiority_desc>
            <p_value>0.23</p_value>
            <p_value_desc>The number of recruited patients did not reach the required sample size. Power score assessments no longer hold, thus there is low confidence in the findings.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison between groups at 3-month timepoint.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Equivalence defined as less than or equal to 1 standard deviation between the two means.</non_inferiority_desc>
            <p_value>0.10</p_value>
            <p_value_desc>The number of recruited patients did not reach the required sample size. Power score assessments no longer hold, thus there is low confidence in the findings.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison between groups at 12-month timepoint.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Equivalence defined as less than or equal to 1 standard deviation between the two means.</non_inferiority_desc>
            <p_value>0.98</p_value>
            <p_value_desc>The number of recruited patients did not reach the required sample size. Power score assessments no longer hold, thus there is low confidence in the findings.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison between groups at 24-month timepoint.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Equivalence defined as less than or equal to 1 standard deviation between the two means.</non_inferiority_desc>
            <p_value>0.50</p_value>
            <p_value_desc>The number of recruited patients did not reach the required sample size. Power score assessments no longer hold, thus there is low confidence in the findings.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Health Related Quality of Life EQ-5D</title>
        <description>Comparing functional and clinical outcomes using the EQ-5D. The EQ-5D-3L descriptive system comprises the following 5 dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 3 levels: no problems, some problems, extreme problems. The participant is asked to indicate his/her health state by indicating the most appropriate level for each of the 5 dimensions. Responses may be converted into a single summary index by applying a formula that essentially attaches values (also called weights) to each of the levels in each dimension. The index can be calculated by deducting the appropriate weights from 1= the value for full health. The EQ VAS records the participant's self-rated health on a vertical, visual analogue scale where the endpoints are labelled from 100 ='Best imaginable health state' to 0= 'Worst imaginable health state'.</description>
        <time_frame>24 months/ 2years</time_frame>
        <population>The number of recruited patients did not reach the required sample size. 1 patient in the Total Knee study arm was consented incorrectly and their data could not be used in analyses (i.e. reducing the number of participants in this study arm to 8).</population>
        <group_list>
          <group group_id="O1">
            <title>Bicompartmental Knee Replacement (BKR)</title>
            <description>Receiving Restoris MCK Multicompartmental Knee System for Bicompartmental Knee Replacement (BKR). Surgery performed using Stryker's robotic-arm assisted surgery system Mako&#xD;
Restoris MCK Multicompartmental Knee System: Bicompartmental Knee Replacement</description>
          </group>
          <group group_id="O2">
            <title>Total Knee Replacement (TKR)</title>
            <description>Receiving Stryker Triathlon Primary Total Knee System for Total Knee Replacement. Surgery performed using Stryker's robotic-arm assisted surgery system Mako&#xD;
Stryker Triathlon Primary Total Knee System: Total Knee Replacement</description>
          </group>
        </group_list>
        <measure>
          <title>Health Related Quality of Life EQ-5D</title>
          <description>Comparing functional and clinical outcomes using the EQ-5D. The EQ-5D-3L descriptive system comprises the following 5 dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 3 levels: no problems, some problems, extreme problems. The participant is asked to indicate his/her health state by indicating the most appropriate level for each of the 5 dimensions. Responses may be converted into a single summary index by applying a formula that essentially attaches values (also called weights) to each of the levels in each dimension. The index can be calculated by deducting the appropriate weights from 1= the value for full health. The EQ VAS records the participant's self-rated health on a vertical, visual analogue scale where the endpoints are labelled from 100 ='Best imaginable health state' to 0= 'Worst imaginable health state'.</description>
          <population>The number of recruited patients did not reach the required sample size. 1 patient in the Total Knee study arm was consented incorrectly and their data could not be used in analyses (i.e. reducing the number of participants in this study arm to 8).</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-op EQ-5D Index</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8"/>
                    <count group_id="O2" value="8"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.16" spread="0.45"/>
                    <measurement group_id="O2" value="0.28" spread="0.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pre-op EQ-5D VAS</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8"/>
                    <count group_id="O2" value="8"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78.50" spread="12.22"/>
                    <measurement group_id="O2" value="81.50" spread="12.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3-month EQ-5D Index</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8"/>
                    <count group_id="O2" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.69" spread="0.35"/>
                    <measurement group_id="O2" value="0.66" spread="0.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3-month EQ-5D VAS</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8"/>
                    <count group_id="O2" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82.25" spread="12.67"/>
                    <measurement group_id="O2" value="90.00" spread="13.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12-month EQ-5D Index</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                    <count group_id="O2" value="5"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.48" spread="0.41"/>
                    <measurement group_id="O2" value="0.65" spread="0.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12-month EQ-5D VAS</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                    <count group_id="O2" value="5"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.50" spread="10.13"/>
                    <measurement group_id="O2" value="89.20" spread="10.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24-month EQ-5D Index</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="5"/>
                    <count group_id="O2" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.63" spread="0.62"/>
                    <measurement group_id="O2" value="0.89" spread="0.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24-month EQ-5D VAS</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="5"/>
                    <count group_id="O2" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.40" spread="11.36"/>
                    <measurement group_id="O2" value="87.25" spread="10.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>To compare EQ-5D Index preoperatively between both groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Equivalence defined as less than or equal to 1 standard deviation between the two means.</non_inferiority_desc>
            <p_value>0.59</p_value>
            <p_value_desc>The number of recruited patients did not reach the required sample size. Power score assessments no longer hold, thus there is low confidence in the findings.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>To compare EQ-5D index at 3-months between both groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Equivalence defined as less than or equal to 1 standard deviation between the two means.</non_inferiority_desc>
            <p_value>0.90</p_value>
            <p_value_desc>The number of recruited patients did not reach the required sample size. Power score assessments no longer hold, thus there is low confidence in the findings.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>To compare EQ-5D index at 12-months between both groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Equivalence defined as less than or equal to 1 standard deviation between the two means.</non_inferiority_desc>
            <p_value>0.57</p_value>
            <p_value_desc>The number of recruited patients did not reach the required sample size. Power score assessments no longer hold, thus there is low confidence in the findings.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>To compare EQ-5D index at 24-months between both groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Equivalence defined as less than or equal to 1 standard deviation between the two means.</non_inferiority_desc>
            <p_value>0.49</p_value>
            <p_value_desc>The number of recruited patients did not reach the required sample size. Power score assessments no longer hold, thus there is low confidence in the findings.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>To compare EQ-5D VAS preoperatively between both groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Equivalence defined as less than or equal to 1 standard deviation between the two means</non_inferiority_desc>
            <p_value>0.65</p_value>
            <p_value_desc>The number of recruited patients did not reach the required sample size. Power score assessments no longer hold, thus there is low confidence in the findings.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>To compare EQ-5D VAS at 3-months between both groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Equivalence defined as less than or equal to 1 standard deviation between the two means.</non_inferiority_desc>
            <p_value>0.30</p_value>
            <p_value_desc>The number of recruited patients did not reach the required sample size. Power score assessments no longer hold, thus there is low confidence in the findings.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>To compare EQ-5D VAS at 12-months between both groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Equivalence defined as less than or equal to 1 standard deviation between the two means.</non_inferiority_desc>
            <p_value>0.06</p_value>
            <p_value_desc>The number of recruited patients did not reach the required sample size. Power score assessments no longer hold, thus there is low confidence in the findings.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>To compare EQ-5D VAS at 24-months between both groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Equivalence defined as less than or equal to 1 standard deviation between the two means.</non_inferiority_desc>
            <p_value>0.44</p_value>
            <p_value_desc>The number of recruited patients did not reach the required sample size. Power score assessments no longer hold, thus there is low confidence in the findings.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>VAS Pain</title>
        <description>Comparing functional and clinical outcomes using the VAS pain. Pain at rest and pain during mobilization are measured using a 10 centimeter Visual Analogue Scale (VAS). Participants are asked to indicate their level of pain with 0 being no pain and 100 being the worst pain.</description>
        <time_frame>24 months/ 2years</time_frame>
        <population>The number of recruited patients did not reach the required sample size. 1 patient in the Total Knee study arm was consented incorrectly and their data could not be used in analyses (i.e. reducing the number of participants in this study arm to 8).</population>
        <group_list>
          <group group_id="O1">
            <title>Bicompartmental Knee Replacement (BKR)</title>
            <description>Receiving Restoris MCK Multicompartmental Knee System for Bicompartmental Knee Replacement (BKR). Surgery performed using Stryker's robotic-arm assisted surgery system Mako&#xD;
Restoris MCK Multicompartmental Knee System: Bicompartmental Knee Replacement</description>
          </group>
          <group group_id="O2">
            <title>Total Knee Replacement (TKR)</title>
            <description>Receiving Stryker Triathlon Primary Total Knee System for Total Knee Replacement. Surgery performed using Stryker's robotic-arm assisted surgery system Mako&#xD;
Stryker Triathlon Primary Total Knee System: Total Knee Replacement</description>
          </group>
        </group_list>
        <measure>
          <title>VAS Pain</title>
          <description>Comparing functional and clinical outcomes using the VAS pain. Pain at rest and pain during mobilization are measured using a 10 centimeter Visual Analogue Scale (VAS). Participants are asked to indicate their level of pain with 0 being no pain and 100 being the worst pain.</description>
          <population>The number of recruited patients did not reach the required sample size. 1 patient in the Total Knee study arm was consented incorrectly and their data could not be used in analyses (i.e. reducing the number of participants in this study arm to 8).</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-op VAS Pain at rest</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8"/>
                    <count group_id="O2" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.63" spread="26.89"/>
                    <measurement group_id="O2" value="36.14" spread="21.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pre-op VAS Pain at mobilization</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8"/>
                    <count group_id="O2" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65.00" spread="25.63"/>
                    <measurement group_id="O2" value="56.86" spread="25.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3-month VAS Pain at rest</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                    <count group_id="O2" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.00" spread="17.45"/>
                    <measurement group_id="O2" value="22.25" spread="18.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3-month VAS Pain at mobilization</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="6"/>
                    <count group_id="O2" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.67" spread="29.44"/>
                    <measurement group_id="O2" value="24.25" spread="16.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12-month VAS Pain at rest</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="5"/>
                    <count group_id="O2" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.40" spread="9.41"/>
                    <measurement group_id="O2" value="19.00" spread="32.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12-month VAS Pain at mobilization</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="5"/>
                    <count group_id="O2" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.60" spread="9.65"/>
                    <measurement group_id="O2" value="24.25" spread="34.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24-month VAS Pain at rest</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="3"/>
                    <count group_id="O2" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.67" spread="0.47"/>
                    <measurement group_id="O2" value="3.50" spread="2.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24-month VAS Pain at mobilization</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="3"/>
                    <count group_id="O2" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.33" spread="1.70"/>
                    <measurement group_id="O2" value="7.75" spread="4.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>To compare VAS Pain at Rest preoperatively between both groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Equivalence defined as less than or equal to 1 standard deviation between the two means.</non_inferiority_desc>
            <p_value>0.97</p_value>
            <p_value_desc>The number of recruited patients did not reach the required sample size. Power score assessments no longer hold, thus there is low confidence in the findings.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>To compare VAS Pain at Rest at 3-months between both groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Equivalence defined as less than or equal to 1 standard deviation between the two means.</non_inferiority_desc>
            <p_value>0.45</p_value>
            <p_value_desc>The number of recruited patients did not reach the required sample size. Power score assessments no longer hold, thus there is low confidence in the findings.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>To compare VAS Pain at Rest at 12-months between both groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Equivalence defined as less than or equal to 1 standard deviation between the two means.</non_inferiority_desc>
            <p_value>0.64</p_value>
            <p_value_desc>The number of recruited patients did not reach the required sample size. Power score assessments no longer hold, thus there is low confidence in the findings.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>To compare VAS Pain at Rest at 24-months between both groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Equivalence defined as less than or equal to 1 standard deviation between the two means.</non_inferiority_desc>
            <p_value>0.19</p_value>
            <p_value_desc>The number of recruited patients did not reach the required sample size. Power score assessments no longer hold, thus there is low confidence in the findings.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>To compare VAS Pain at Mobilisation preoperatively between both groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Equivalence defined as less than or equal to 1 standard deviation between the two means.</non_inferiority_desc>
            <p_value>0.57</p_value>
            <p_value_desc>The number of recruited patients did not reach the required sample size. Power score assessments no longer hold, thus there is low confidence in the findings.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>To compare VAS Pain at Mobilisation at 3-months between both groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Equivalence defined as less than or equal to 1 standard deviation between the two means.</non_inferiority_desc>
            <p_value>0.98</p_value>
            <p_value_desc>The number of recruited patients did not reach the required sample size. Power score assessments no longer hold, thus there is low confidence in the findings.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>To compare VAS Pain at Mobilisation at 12-months between both groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Equivalence defined as less than or equal to 1 standard deviation between the two means.</non_inferiority_desc>
            <p_value>0.58</p_value>
            <p_value_desc>The number of recruited patients did not reach the required sample size. Power score assessments no longer hold, thus there is low confidence in the findings.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>To compare VAS Pain at Mobilisation at 24-months between both groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Equivalence defined as less than or equal to 1 standard deviation between the two means.</non_inferiority_desc>
            <p_value>0.16</p_value>
            <p_value_desc>The number of recruited patients did not reach the required sample size. Power score assessments no longer hold, thus there is low confidence in the findings.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>New Knee Society Score (KSS)</title>
        <description>Comparing functional and clinical outcomes using the KSS. The Knee Society Clinical Rating System is comprised of two distinct sub-scores: one for pain, range of motion (ROM) and joint stability, and one for functional parameters. Sub-scores range from a minimum score of 0 to a maximum of 100 points. Although the specific scores are not distinguished as &quot;excellent,&quot; &quot;good,&quot; &quot;fair,&quot; or &quot;poor,&quot; a higher value represents a better outcome.</description>
        <time_frame>24 months/ 2years</time_frame>
        <population>The number of recruited patients did not reach the required sample size. 1 patient in the Total Knee study arm was consented incorrectly and their data could not be used in analyses (i.e. reducing the number of participants in this study arm to 8).</population>
        <group_list>
          <group group_id="O1">
            <title>Bicompartmental Knee Replacement (BKR)</title>
            <description>Receiving Restoris MCK Multicompartmental Knee System for Bicompartmental Knee Replacement (BKR). Surgery performed using Stryker's robotic-arm assisted surgery system Mako&#xD;
Restoris MCK Multicompartmental Knee System: Bicompartmental Knee Replacement</description>
          </group>
          <group group_id="O2">
            <title>Total Knee Replacement (TKR)</title>
            <description>Receiving Stryker Triathlon Primary Total Knee System for Total Knee Replacement. Surgery performed using Stryker's robotic-arm assisted surgery system Mako&#xD;
Stryker Triathlon Primary Total Knee System: Total Knee Replacement</description>
          </group>
        </group_list>
        <measure>
          <title>New Knee Society Score (KSS)</title>
          <description>Comparing functional and clinical outcomes using the KSS. The Knee Society Clinical Rating System is comprised of two distinct sub-scores: one for pain, range of motion (ROM) and joint stability, and one for functional parameters. Sub-scores range from a minimum score of 0 to a maximum of 100 points. Although the specific scores are not distinguished as &quot;excellent,&quot; &quot;good,&quot; &quot;fair,&quot; or &quot;poor,&quot; a higher value represents a better outcome.</description>
          <population>The number of recruited patients did not reach the required sample size. 1 patient in the Total Knee study arm was consented incorrectly and their data could not be used in analyses (i.e. reducing the number of participants in this study arm to 8).</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>KSS function at pre-operation</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="7"/>
                    <count group_id="O2" value="8"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.29" spread="9.65"/>
                    <measurement group_id="O2" value="48.00" spread="15.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>KSS function at 3-month</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8"/>
                    <count group_id="O2" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.44" spread="12.08"/>
                    <measurement group_id="O2" value="61.00" spread="15.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>KSS function at 24-month</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="4"/>
                    <count group_id="O2" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.50" spread="9.39"/>
                    <measurement group_id="O2" value="85.33" spread="10.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>To compare New Knee Society Function Score preoperatively between both groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Equivalence defined as less than or equal to 1 standard deviation between the two means.</non_inferiority_desc>
            <p_value>0.62</p_value>
            <p_value_desc>The number of recruited patients did not reach the required sample size. Power score assessments no longer hold, thus there is low confidence in the findings.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>To compare New Knee Society Function Score at 3-months between both groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Equivalence defined as less than or equal to 1 standard deviation between the two means.</non_inferiority_desc>
            <p_value>0.06</p_value>
            <p_value_desc>The number of recruited patients did not reach the required sample size. Power score assessments no longer hold, thus there is low confidence in the findings.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>To compare New Knee Society Function Score at 24-months between both groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Equivalence defined as less than or equal to 1 standard deviation between the two means.</non_inferiority_desc>
            <p_value>0.93</p_value>
            <p_value_desc>The number of recruited patients did not reach the required sample size. Power score assessments no longer hold, thus there is low confidence in the findings.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Forgotten Joint Score (FJS)</title>
        <description>Comparing functional and clinical outcomes using the FJS. The Forgotten Joint Score (FJS) is a 12 question form that asks the patient their level of awareness of their artificial joint in 12 scenarios commonly encountered in daily life. Scores can range from 0 to 100 with a higher score indicating a better outcome (high degree of forgetting the joint in everyday life).</description>
        <time_frame>24 months/ 2years</time_frame>
        <population>The number of recruited patients did not reach the required sample size. 1 patient in the Total Knee study arm was consented incorrectly and their data could not be used in analyses (i.e. reducing the number of participants in this study arm to 8).</population>
        <group_list>
          <group group_id="O1">
            <title>Bicompartmental Knee Replacement (BKR)</title>
            <description>Receiving Restoris MCK Multicompartmental Knee System for Bicompartmental Knee Replacement (BKR). Surgery performed using Stryker's robotic-arm assisted surgery system Mako&#xD;
Restoris MCK Multicompartmental Knee System: Bicompartmental Knee Replacement</description>
          </group>
          <group group_id="O2">
            <title>Total Knee Replacement (TKR)</title>
            <description>Receiving Stryker Triathlon Primary Total Knee System for Total Knee Replacement. Surgery performed using Stryker's robotic-arm assisted surgery system Mako&#xD;
Stryker Triathlon Primary Total Knee System: Total Knee Replacement</description>
          </group>
        </group_list>
        <measure>
          <title>Forgotten Joint Score (FJS)</title>
          <description>Comparing functional and clinical outcomes using the FJS. The Forgotten Joint Score (FJS) is a 12 question form that asks the patient their level of awareness of their artificial joint in 12 scenarios commonly encountered in daily life. Scores can range from 0 to 100 with a higher score indicating a better outcome (high degree of forgetting the joint in everyday life).</description>
          <population>The number of recruited patients did not reach the required sample size. 1 patient in the Total Knee study arm was consented incorrectly and their data could not be used in analyses (i.e. reducing the number of participants in this study arm to 8).</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>FJS pre-operative</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="4"/>
                    <count group_id="O2" value="5"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.60" spread="3.56"/>
                    <measurement group_id="O2" value="13.75" spread="5.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>FJS 3-month</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8"/>
                    <count group_id="O2" value="7"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51.30" spread="25.92"/>
                    <measurement group_id="O2" value="30.36" spread="25.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>FJS 12-month</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="7"/>
                    <count group_id="O2" value="6"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58.63" spread="27.04"/>
                    <measurement group_id="O2" value="63.19" spread="32.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>FJS 24-month</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="5"/>
                    <count group_id="O2" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64.58" spread="23.46"/>
                    <measurement group_id="O2" value="66.67" spread="19.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Comparison between groups at pre-operation timepoint.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Equivalence defined as less than or equal to 1 standard deviation between the two means.</non_inferiority_desc>
            <p_value>0.57</p_value>
            <p_value_desc>The number of recruited patients did not reach the required sample size. Power score assessments no longer hold, thus there is low confidence in the findings.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>To compare FJS at 3-months between both groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Equivalence defined as less than or equal to 1 standard deviation between the two means.</non_inferiority_desc>
            <p_value>0.17</p_value>
            <p_value_desc>The number of recruited patients did not reach the required sample size. Power score assessments no longer hold, thus there is low confidence in the findings.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>To compare FJS at 12-months between both groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Equivalence defined as less than or equal to 1 standard deviation between the two means.</non_inferiority_desc>
            <p_value>0.80</p_value>
            <p_value_desc>The number of recruited patients did not reach the required sample size. Power score assessments no longer hold, thus there is low confidence in the findings.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>To compare FJS at 24-months between both groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Equivalence defined as less than or equal to 1 standard deviation between the two means.</non_inferiority_desc>
            <p_value>0.90</p_value>
            <p_value_desc>The number of recruited patients did not reach the required sample size. Power score assessments no longer hold, thus there is low confidence in the findings.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Incidence of Loosening, Reoperation and Revision</title>
        <description>To compare incidence of loosening, reoperation and revision rates. The incidence (ie number of participants who experienced lossening, reoperation or revision) will be counted and presented as a whole number or percentage of the total number of patients, however they will be identified from analysing Xrays and checking Serious Adverse Event/ Adverse Event reports.</description>
        <time_frame>6 weeks, 3 months, 12 months, 24 months</time_frame>
        <population>Image quality not obtained to perform incidence calculations thus the incidence of loosening, reoperation and revision detailed below are solely based off the Serious Adverse Events and Adverse Events reported. 1 patient in the Total Knee study arm was consented incorrectly and their data could not be used in analyses (i.e. reducing the number of participants in this study arm to 8).</population>
        <group_list>
          <group group_id="O1">
            <title>Bicompartmental Knee Replacement (BKR)</title>
            <description>Receiving Restoris MCK Multicompartmental Knee System for Bicompartmental Knee Replacement (BKR). Surgery performed using Stryker's robotic-arm assisted surgery system Mako&#xD;
Restoris MCK Multicompartmental Knee System: Bicompartmental Knee Replacement</description>
          </group>
          <group group_id="O2">
            <title>Total Knee Replacement (TKR)</title>
            <description>Receiving Stryker Triathlon Primary Total Knee System for Total Knee Replacement. Surgery performed using Stryker's robotic-arm assisted surgery system Mako&#xD;
Stryker Triathlon Primary Total Knee System: Total Knee Replacement</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence of Loosening, Reoperation and Revision</title>
          <description>To compare incidence of loosening, reoperation and revision rates. The incidence (ie number of participants who experienced lossening, reoperation or revision) will be counted and presented as a whole number or percentage of the total number of patients, however they will be identified from analysing Xrays and checking Serious Adverse Event/ Adverse Event reports.</description>
          <population>Image quality not obtained to perform incidence calculations thus the incidence of loosening, reoperation and revision detailed below are solely based off the Serious Adverse Events and Adverse Events reported. 1 patient in the Total Knee study arm was consented incorrectly and their data could not be used in analyses (i.e. reducing the number of participants in this study arm to 8).</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Incidence of loosening</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Incidence of reoperation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Incidence of revision</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Hospital Stay</title>
        <description>To compare length of hospital stay between the two arms of the study</description>
        <time_frame>6 weeks</time_frame>
        <population>The number of recruited patients did not reach the required sample size. 1 patient in the Total Knee study arm was consented incorrectly and their data could not be used in analyses (i.e. reducing the number of participants in this study arm to 8).</population>
        <group_list>
          <group group_id="O1">
            <title>Bicompartmental Knee Replacement (BKR)</title>
            <description>Receiving Restoris MCK Multicompartmental Knee System for Bicompartmental Knee Replacement (BKR). Surgery performed using Stryker's robotic-arm assisted surgery system Mako&#xD;
Restoris MCK Multicompartmental Knee System: Bicompartmental Knee Replacement</description>
          </group>
          <group group_id="O2">
            <title>Total Knee Replacement (TKR)</title>
            <description>Receiving Stryker Triathlon Primary Total Knee System for Total Knee Replacement. Surgery performed using Stryker's robotic-arm assisted surgery system Mako&#xD;
Stryker Triathlon Primary Total Knee System: Total Knee Replacement</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Hospital Stay</title>
          <description>To compare length of hospital stay between the two arms of the study</description>
          <population>The number of recruited patients did not reach the required sample size. 1 patient in the Total Knee study arm was consented incorrectly and their data could not be used in analyses (i.e. reducing the number of participants in this study arm to 8).</population>
          <units>Number of nights</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" spread="1.32"/>
                    <measurement group_id="O2" value="2.86" spread="0.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>To compare length of hospital stay (number of nights) between both groups.</groups_desc>
            <non_inferiority_type>Equivalence</non_inferiority_type>
            <non_inferiority_desc>Equivalence defined as less than or equal to 1 standard deviation between the two means.</non_inferiority_desc>
            <p_value>0.81</p_value>
            <p_value_desc>The number of recruited patients did not reach the required sample size. Power score assessments no longer hold, thus there is low confidence in the findings.</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>2 years post-operation</time_frame>
      <desc>1 patient in the Total Knee study arm was consented incorrectly and their data could not be used in analyses (i.e. reducing the number of participants in this study arm to 8).</desc>
      <group_list>
        <group group_id="E1">
          <title>Bicompartmental Knee Replacement (BKR)</title>
          <description>Receiving Restoris MCK Multicompartmental Knee System for Bicompartmental Knee Replacement (BKR). Surgery performed using Stryker's robotic-arm assisted surgery system Mako&#xD;
Restoris MCK Multicompartmental Knee System: Bicompartmental Knee Replacement</description>
        </group>
        <group group_id="E2">
          <title>Total Knee Replacement (TKR)</title>
          <description>Receiving Stryker Triathlon Primary Total Knee System for Total Knee Replacement. Surgery performed using Stryker's robotic-arm assisted surgery system Mako&#xD;
Stryker Triathlon Primary Total Knee System: Total Knee Replacement</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Internal Cardiac Defibrillator implanted</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Contralateral knee osteoarthirits</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Contralateral knee pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Contralateral Bicompartmental Knee Replacement</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Sinus and ear infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthrofibrosis</sub_title>
                <description>(operative side)</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Lateral knee pain and anterior fat pad impingement</sub_title>
                <description>(operative side)</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Anterior medial foot pain</sub_title>
                <description>(operative side)</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Plantar fasciitis</sub_title>
                <description>(operative side)</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Since the study has been discontinued due to the sample size not being reached, the data cannot be analysed and there are no trial results to discuss/ publish.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>There existed complexities in recruiting patients that complied with the inclusion and exclusion criteria of the study. The randomised nature of this study required detailed criteria, yet it was difficult in recruiting patients suitable for both bicompartmental and total knee replacement surgeries.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Alissa Connelly</name_or_title>
      <organization>Stryker</organization>
      <phone>+61294671000 ext 1075</phone>
      <email>alissa.connelly@stryker.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

